Fuller & Thaler Asset Management, Inc. Eli Lilly & CO Transaction History

Fuller & Thaler Asset Management, Inc.

$25 Billion
Q3 2024

A detailed history of Fuller & Thaler Asset Management, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Fuller & Thaler Asset Management, Inc. holds 3,267 shares of LLY stock, worth $2.6 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

3,267

Previous 3,267 -0.0%

Holding current value

$2.6 Million

Previous $2.96 Million 2.13%

% of portfolio

0.01%

Previous 0.01%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$592.2 - $792.28 $303,206 - $405,647	-512 Reduced 13.55%	3,267 $2.54 Million
Q4 2023 Feb 13, 2024	BUY	$525.19 - $619.13 $380,762 - $448,869	725 Added 23.74%	3,779 $2.2 Million
Q3 2023 Nov 13, 2023	BUY	$434.7 - $599.3 $86,940 - $119,859	200 Added 7.01%	3,054 $1.64 Million
Q2 2023 Aug 14, 2023	BUY	$350.74 - $468.98 $245,167 - $327,817	699 Added 32.44%	2,854 $1.34 Million
Q4 2022 Feb 13, 2023	SELL	$321.55 - $374.67 $409,976 - $477,704	-1,275 Reduced 37.17%	2,155 $788,000
Q3 2022 Nov 14, 2022	SELL	$296.48 - $337.87 $743,868 - $847,715	-2,509 Reduced 42.25%	3,430 $1.11 Million
Q2 2022 Aug 12, 2022	SELL	$278.73 - $327.27 $975,555 - $1.15 Million	-3,500 Reduced 37.08%	5,939 $1.93 Million
Q1 2022 May 13, 2022	SELL	$234.69 - $291.66 $751,008 - $933,312	-3,200 Reduced 25.32%	9,439 $2.7 Million
Q4 2021 Feb 09, 2022	SELL	$224.85 - $279.04 $404,730 - $502,272	-1,800 Reduced 12.47%	12,639 $3.49 Million
Q3 2021 Nov 10, 2021	SELL	$221.6 - $272.71 $221,600 - $272,710	-1,000 Reduced 6.48%	14,439 $3.34 Million
Q2 2021 Aug 13, 2021	SELL	$180.55 - $233.54 $469,430 - $607,204	-2,600 Reduced 14.41%	15,439 $3.54 Million
Q1 2021 May 13, 2021	SELL	$164.32 - $212.72 $558,688 - $723,248	-3,400 Reduced 15.86%	18,039 $3.37 Million
Q4 2020 Feb 11, 2021	BUY	$130.46 - $172.63 $5,087 - $6,732	39 Added 0.18%	21,439 $3.62 Million
Q1 2020 May 06, 2020	SELL	$119.05 - $147.35 $785,730 - $972,510	-6,600 Reduced 23.57%	21,400 $2.97 Million
Q4 2019 Feb 14, 2020	BUY	$106.92 - $132.43 $2.99 Million - $3.71 Million	28,000 New	28,000 $3.68 Million
Q3 2018 Nov 13, 2018	SELL	$85.86 - $107.31 $446,472 - $558,012	-5,200 Closed	0 $0
Q1 2018 May 14, 2018	SELL	$74.21 - $87.6 $422,996 - $499,319	-5,700 Reduced 52.29%	5,200 $402,000
Q3 2017 Nov 08, 2017	SELL	$77.07 - $85.54 $46,241 - $51,324	-600 Reduced 5.22%	10,900 $932,000
Q2 2017 Aug 14, 2017	BUY	N/A	11,500	11,500 $946,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fuller & Thaler Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Fuller & Thaler Asset Management, Inc. with notifications on news.

Account

Fuller & Thaler Asset Management, Inc. Eli Lilly & CO Transaction History